Supplementary Table S2 from RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition

Supplementary Table S2

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Yufang Bao (15386826) (author)
Diğer Yazarlar:	Sirui Zhang (15386829) (author), Xiaoyu Zhang (15386832) (author), Yunjian Pan (15386835) (author), Yueren Yan (15386838) (author), Ning Wang (15386841) (author), Yunpeng Ren (15386844) (author), Ji Zuo (15386847) (author), Wei-Xing Zong (15386850) (author), Zefeng Wang (15386853) (author), Yongbo Wang (15386856) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Biology Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Computational Methods Sequence analysis Drug Resistance Regulation of gene expression in drug resistance Reversal of drug resistance Gene Regulation Posttranscriptional and translational control Lung Cancer Oncogenes & Tumor Suppressors Tumor suppressor genes Preclinical Models Animal models of cancer
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Supplementary Table S2 from <i>RBM10</i> Loss Promotes <i>EGFR</i>-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition